Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy
NCT01185145 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 291
Last updated 2013-07-11
Summary
Accelerated Partial Breast Irradiation by Mammosite and intensity modulated radiotherapy is safe and effective in patients with early stage breast cancer resected by lumpectomy.
Conditions
Interventions
- RADIATION
-
Breast Brachytherapy with Mammosite RTS
Treatment will be performed using high dose rate brachytherapy, starting between 2-5 days of implant, 34 Gy at 1 cm in 3.4 Gy fractions BID for 5 treatment days with typical boost dose od 10 Gy given in 2 fractions at least 6 hours apart.
- RADIATION
-
Intensity Modulated Radiotherapy
Accelerated Partial Breast Irradiation using intensity modulated radiotherapy, a novel planning and delivery technique for external beam radiation
Sponsors & Collaborators
-
Charles Leonard, MD
collaborator UNKNOWN -
Rocky Mountain Cancer Centers
lead OTHER
Principal Investigators
-
Dennis Carter, MD · Rocky Mountain Cancer Centers
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-02-29
- Primary Completion
- 2014-08-31
- Completion
- 2024-08-31
Countries
- United States
Study Locations
More Related Trials
-
BrUOG 351: PRE-OPERATIVE APBI USING NIBB
NCT03437915 ·Status: WITHDRAWN ·Phase: NA
-
Preoperative Accelerated Partial Breast Irradiation for Triple Negative Breast Cancer Using Proton Beam Scanning
NCT03340402 ·Status: WITHDRAWN ·Phase: NA
-
A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRT
NCT04509765 ·Status: COMPLETED ·Phase: NA
-
Ablative SBRT in Elderly BC Patients
NCT06523894 ·Status: RECRUITING ·Phase: NA
-
Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer
NCT03345420 ·Status: COMPLETED ·Phase: PHASE2
-
A Study For Using Radiosurgery On Limited Metastases
NCT00178399 ·Status: COMPLETED ·Phase: NA
-
Phase II Study of Whole or Partial Parotid Sparing Intensity Modulated Radiotherapy in Patients With Head and Neck Cancers
NCT02068313 ·Status: UNKNOWN
-
Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases
NCT02933242 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer.
NCT00279721 ·Status: COMPLETED ·Phase: PHASE2
-
Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma
NCT06905132 ·Status: RECRUITING ·Phase: PHASE2
-
Hypofractionated Stereotactic Body Radiation Therapy (SBRT)
NCT01288534 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc)
NCT03548428 ·Status: RECRUITING ·Phase: PHASE2
-
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors
NCT03721341 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Elective Adaptive Radiation With SBRT for Improved DurabilitY of Response
NCT06831032 ·Status: RECRUITING ·Phase: NA
-
Once Daily Accelerated Fractionation With Concomitant Boost to the Gross Tumor Volume Compared With Twice Daily Hyperfractionation in Concurrent Chemoradiation in Patients With Limited Disease Small Cell Lung Cancer
NCT01710956 ·Status: UNKNOWN ·Phase: PHASE2
-
Breast Stereotactic Radiotherapy to Primary Tumors in Metastatic Patients
NCT05229575 ·Status: UNKNOWN ·Phase: NA
-
Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy
NCT01223248 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
SBRT + Atezolizumab + Bevacizumab in Resectable HCC
NCT04857684 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)
NCT04985032 ·Status: RECRUITING
-
Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study
NCT01836692 ·Status: COMPLETED ·Phase: NA
-
Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases
NCT01586104 ·Status: COMPLETED ·Phase: NA
-
Prospecitve Observational Study on a Risk Adaptive Scheme for SBRT for Thoracic Nodes Metastases
NCT02970955 ·Status: COMPLETED
-
Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy
NCT01777802 ·Status: COMPLETED
-
5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases
NCT01761929 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Dose Intensified Radiotherapy of Spinal Metastases by Hypofractionated Radiation and IGRT hfSRT Mediated Boost
NCT01849510 ·Status: UNKNOWN ·Phase: PHASE2